{
  "id": "dka_management_multipleChoice_v1",
  "type": "multipleChoice",
  "stem": "A patient with Diabetic Ketoacidosis (DKA) has a blood glucose of 240 mg/dL and is receiving IV regular insulin. Which IV fluid should the nurse anticipate administering next?",
  "options": [
    {
      "id": "b",
      "text": "5% Dextrose in 0.45% Normal Saline"
    },
    {
      "id": "a",
      "text": "0.9% Normal Saline"
    },
    {
      "id": "d",
      "text": "Lactated Ringer's"
    },
    {
      "id": "c",
      "text": "3% Hypertonic Saline"
    }
  ],
  "correctOptionId": "b",
  "pedagogy": {
    "bloomLevel": "apply",
    "cjmmStep": "takeAction",
    "nclexCategory": "Physiological Adaptation",
    "difficulty": 4,
    "topicTags": [
      "DKA",
      "Insulin",
      "Endocrine",
      "IV Fluids"
    ]
  },
  "answerBreakdown": [
    {
      "key": "b",
      "content": "Once blood glucose reaches approximately 250 mg/dL (13.9 mmol/L) during DKA treatment, the IV fluid should be changed to a dextrose-containing solution, such as 5% Dextrose in 0.45% Normal Saline. \n\n**Pathophysiology:** In DKA, insulin deficiency leads to hyperglycemia and increased lipolysis, resulting in excess ketone production and metabolic acidosis. IV insulin is crucial to suppress ketogenesis and facilitate glucose utilization by cells. However, continuing insulin infusion without a glucose source once the blood glucose nears 250 mg/dL can cause rapid hypoglycemia. Dextrose administration provides an exogenous glucose source, allowing the insulin infusion to continue safely, resolving the acidosis and preventing hypoglycemia.\n\n**Clinical Pearl:** Monitor the patient closely for signs of fluid overload and electrolyte imbalances, especially hypokalemia, during IV fluid administration. Frequent blood glucose monitoring is essential to adjust the insulin infusion rate and dextrose concentration as needed.",
      "isCorrect": true
    },
    {
      "key": "a",
      "content": "0.9% Normal Saline is the initial fluid of choice for volume resuscitation in DKA due to the significant dehydration caused by osmotic diuresis from hyperglycemia. \n\n**Pathophysiology:** Hyperglycemia in DKA causes osmotic diuresis, leading to severe dehydration and electrolyte loss. Initial fluid resuscitation with isotonic saline (0.9% Normal Saline) helps restore intravascular volume and improve tissue perfusion. However, at a blood glucose of 240 mg/dL, continuing only with 0.9% Normal Saline while administering IV insulin increases the risk of hypoglycemia. The priority shifts to preventing hypoglycemia while continuing to address the underlying metabolic acidosis.\n\n**Clinical Pearl:** While 0.9% Normal Saline is crucial for initial volume repletion, prolonged administration can lead to hyperchloremic metabolic acidosis. Monitor serum electrolytes and acid-base balance closely.",
      "isCorrect": false
    },
    {
      "key": "d",
      "content": "Lactated Ringer's (LR) is an isotonic crystalloid solution that is sometimes used in DKA management, but it is not the preferred fluid when transitioning to maintenance fluids. \n\n**Pathophysiology:** LR contains lactate, which the liver converts to bicarbonate, potentially aiding in correcting metabolic acidosis. However, in DKA, hepatic function may be impaired due to dehydration and decreased perfusion, limiting the effectiveness of lactate conversion. Furthermore, LR does not contain dextrose, which is needed at this glucose level to prevent hypoglycemia from the insulin infusion. The standard of care, especially when transitioning to a maintenance fluid, is a saline-based solution with dextrose.\n\n**Clinical Pearl:** Avoid LR in patients with severe liver dysfunction or hyperkalemia, as it may exacerbate these conditions. Monitor lactate levels and liver function tests if LR is used.",
      "isCorrect": false
    },
    {
      "key": "c",
      "content": "3% Hypertonic Saline is contraindicated in DKA. \n\n**Pathophysiology:** DKA causes hyperosmolarity due to elevated blood glucose levels. Hypertonic saline further increases serum osmolality, exacerbating cellular dehydration, particularly in the brain. This can lead to severe neurological complications, such as central pontine myelinolysis or seizures. Hypertonic saline is reserved for treating severe symptomatic hyponatremia or cerebral edema, not hyperglycemia-induced hyperosmolarity.\n\n**Clinical Pearl:** Never administer hypertonic saline to patients with DKA unless they have a concurrent, life-threatening condition requiring it (e.g., severe hyponatremia with cerebral edema from another cause). Closely monitor serum sodium and osmolality if hypertonic saline is used for other indications.",
      "isCorrect": false
    }
  ],
  "questionTrap": "The primary trap is focusing solely on the blood glucose value of 240 mg/dL, which is still elevated, and concluding that administering dextrose is incorrect. This overlooks the core pathophysiology of DKA: the goal of the insulin infusion is to stop ketogenesis and resolve acidosis, not just to lower blood glucose. The dextrose is a 'safety net' that allows the insulin to continue working on the acidosis without causing a hypoglycemic crisis.",
  "mnemonics": "'When the sugar hits 250, get the D5 ready to go!' This reminds the nurse of the specific blood glucose threshold for changing IV fluids. Another mnemonic is 'Insulin for the acid, Dextrose for the brain,' highlighting the dual goals of resolving ketoacidosis while preventing hypoglycemia and protecting neurological function.",
  "scoring": {
    "method": "dichotomous",
    "maxPoints": 1
  },
  "sbar": {
    "situation": "Patient with Diabetic Ketoacidosis (DKA) and blood glucose of 240 mg/dL receiving IV regular insulin.",
    "background": "Patient presented with hyperglycemia, dehydration, and metabolic acidosis consistent with DKA. Initial treatment included IV fluids (0.9% Normal Saline) and IV regular insulin. Blood glucose has decreased to 240 mg/dL.",
    "assessment": "Blood glucose is decreasing, but the patient requires continued insulin infusion to resolve ketoacidosis. Continuing current IV fluids may lead to hypoglycemia.",
    "recommendation": "Change IV fluids to 5% Dextrose in 0.45% Normal Saline to prevent hypoglycemia while continuing insulin infusion. Monitor blood glucose hourly and adjust insulin infusion rate as needed. Assess electrolytes, particularly potassium, every 2-4 hours. Notify provider of any significant changes. Next blood glucose check due at 1400."
  },
  "sentinelStatus": "healed_v2026_v8",
  "rationale": {
    "correct": "Clinical rationale pending deep clinical alignment."
  }
}